Malignant course of invasive pulmonary aspergillosis in the new coronavirus infection COVID-19

During the COVID-19 pandemic, the registration of respiratory fungal pathology, especially pulmonary aspergillosis, has increased significantly. We present a histopathologically confirmed case of fatal invasive pulmonary aspergillosis (IPA) complicating COVID-19. A 65-year-old patient with long-term diabetes backgrounded with a severe course of COVID-19 ( the virus was identified ICD-10 code U07.1) described. During the illness bilateral polysegmental pneumonia of fungal-bacterial (Klebsiella pneumoniae) etiology with necrosis and sequestration of the affected tissue the lower lobe of the right lung with the formation of a "fungal ball" and the development of a right-sided pneumothorax was developed. In other parts of both lungs, focal destruction of the interalveolar septa was determined with the formation of small cavities filled with detritus and accumulations of segmented neutrophils, with the proliferation of fungal mycelium, positively stained in the PAS reaction. Fungal hyphae and conidial heads were also found in the lumens of individual bronchi and vessels with invasion of their walls. Long-term (more than one month) course of the disease, clinical and radiological dynamics, and detection of a forming connective tissue capsule along the periphery of the necrosis zone during microscopy testifies in favor of the subacute nature of the infection. The presented clinical case, as well as a review of current publications and meta-analyses on IPA, point to diagnostic problems and poor outcomes of IPA in patients with COVID-19.